ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders

Abstract

AbstractObjectivesTo evaluate the diagnostic performance of platelet function analyzer (PFA) and The International Society on Thrombosis and Hemostasis bleeding‐assessment‐tool (ISTH‐BAT) in detecting mild inherited platelet function disorders (IPFDs) in children with suspected bleeding disorders.MethodsProspective single‐center diagnostic study including consecutive patients <18 years with suspected bleeding disorder and performing a standardized workup for platelet function defects including ISTH‐BAT, PFA, platelet aggregation testing, blood smear‐based immunofluorescence, and next‐generation sequencing‐based genetic screening for IPFDs.ResultsWe studied 97 patients, of which 34 von Willebrand disease (VWD, 22 type‐1, 11 type‐2), 29 IPFDs (including delta−/alpha‐storage pool disease, Glanzmann thrombasthenia, Hermansky–Pudlak syndrome) and 34 with no diagnosis. In a model combining PFA‐adenosine diphosphate (ADP), PFA‐epinephrine (EPI), and ISTH‐BAT overall performance to diagnose IPFDs was low with area under the curves of 0.56 (95% CI 0.44, 0.69) compared with 0.84 (95% CI 0.76, 0.92) for VWD. Correlation of PFA‐EPI/‐ADP and ISTH‐BAT was low with 0.25/0.39 Spearman's correlation coefficients. PFA were significantly prolonged in patients with VWD and Glanzmann thrombasthenia. ISTH‐BAT‐scores were only positive in severe bleeding disorders, but not in children with mild IPFDs or VWD.ConclusionNeither ISTH‐BAT nor PFA or the combination of both help diagnosing mild IPFDs in children. PFA is suited to exclude severe IPFDs or VWD and is in this regard superior to ISTH‐BAT in children.